| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.0065 | 0.9 |